Sotagliflozin could be used to reduce the risk of deadly cardiovascular events, trial shows
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, highlighting ...
A multicentre trial in China finds that combining SGLT-2 inhibitors with calorie restriction improves remission, weight loss, and metabolic health ...
GLP1R gene variants link to cardiometabolic traits and behavioral changes, but findings suggest behavioral effects of GLP1RA are indirect Study: ...
Factors such as sex, type of insurance plan, and the use of common medications influenced whether individuals with obesity but ...
A systematic review of 573,173 individuals with type 2 diabetes found South Asian, Black, and Chinese ethnic groups have significantly ...
When children with obesity undergo weight-loss treatment, the effects have repercussions later in life and the risk of serious health ...
Researchers discover a gut-microbe-driven pathway involving pantothenate and GLP-1 that could revolutionize sugar consumption management and metabolic health strategies. Study: ...
Sugary drinks are fueling rising rates of diabetes and heart disease worldwide—and what must be done to curb their devastating ...
Global study links sugar-sweetened beverages to millions of diabetes and heart disease cases, with developing regions facing the greatest burden ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net